Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/3/2020
SIETES contiene 92954 citas

 
 
 1 a 15 de 15 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Kao JC, Liao B, Markovic SN, Klein CJ, Naddaf E, Staff NP, Liewluck T, Hammack JE, Sandroni P, Finnes H, Mauermann ML. Neurological complications associated with anti-programmed death 1 (PD-1) antibodies. JAMA Neurology 2017:5 de septiembre. [Ref.ID 102058]
2. Cita con resumen
de Maleissye M-F, Nicolas G, Saiag P. Pembrolizumab-induced demyelinating polyradiculoneuropathy. N Engl J Med 2016;375:296-7. [Ref.ID 100503]
3. Cita con resumen
Etminan M, Brophy JM, Samii A. Oral fluoroquinolone use and risk of peripheral neuropathy. A pharmacoepidemiologic study. Neurology 2014;83:1261-3. [Ref.ID 98250]
4. Cita con resumen
Hughes R. Investigation of peripheral neuropathy. BMJ 2010;341:1161-2. [Ref.ID 89724]
5. Cita con resumen
Black S, Eskola J, Siegrist CA, Halsey N, MacDonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009;374:2115-22. [Ref.ID 87323]
6. Cita con resumen
Hollak CEM, Hughes D, van Schaik IN, Schwierin B, Bembi B. Miglustat (Zavesca) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme. Pharmacoepidemiol Drug Saf 2009;18:770-7. [Ref.ID 86558]
7. Cita con resumen
Rizzetti MC, Liberini P, Zarattini G, Catalani S, Pazzaglia U, Apostoli P, Padovani A. Loss of sight and sound. Could it be the hip?. Lancet 2009;373:1052. [Ref.ID 85510]
8. Cita con resumen
Freeman R. Autonomic peripheral neuropathy. Lancet 2005;365:1259-70. [Ref.ID 73309]
9. Cita con resumen
England JD, Asbury AK. Peripheral neuropathy. Lancet 2004;363:2151-61. [Ref.ID 70566]
11. Cita con resumen
Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Vinik A, Giuliani M, Stevens JC, Barbano R, Dyck PJ, for the rhNGF Clinical Investigator Group. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy. A randomized controlled trial. JAMA 2000;284:2215-21. [Ref.ID 53498]
12. Cita con resumen
Anónimo. Polyneuropathies périphériques dues aux "statines". Prescrire 2000;20:279. [Ref.ID 50307]
13.
Jeppesen U, Gaist D, Smith T, Sindrup SH. Statins and peripheral neuropathy. Eur J Clin Pharmacol 1999;54:835-8. [Ref.ID 42686]
14.
Anónimo. Influenza vaccines - acute febrile polyneuritis. Germany. WHO Pharmaceuticals Newsletter 1997;7-8:7. [Ref.ID 37479]
15.
Ordúñez-García PO, Nieto F J, Espinosa-Brito AD, Caballero B. Cuban epidemic neuropathy, 1991 to 1994: history repeats itself a century after the "Amblyopia of the blockade". Am J Public Health 1996;86:738-43. [Ref.ID 28137]
Seleccionar todas
 
 1 a 15 de 15